Single-Detector Gamma Camera Market Report 2026

The single-detector gamma camera market size has grown strongly in recent years. It will grow from $0.87 billion in 2025 to $0.93 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, increasing adoption of nuclear medicine diagnostics, growing geriatric population, expanding healthcare infrastructure, and increasing demand for early disease detection.

The single-detector gamma camera market size is expected to see strong growth in the next few years. It will grow to $1.25 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing global burden of cancer and cardiovascular diseases, growing investment in healthcare infrastructure (especially in emerging markets), rising adoption of advanced gamma camera systems, expanding use of nuclear medicine in diagnostics and research, and rising demand for non‑invasive diagnostic imaging. Major trends in the forecast period include technology advancements in detectors and imaging systems, innovations in hybrid imaging, developments in digital and solid‑state gamma cameras, research and development of novel radiopharmaceuticals and imaging protocols, and increasing integration of artificial intelligence (AI) and image‑processing automation.

The rising prevalence of cancer and cardiovascular diseases is expected to propel the growth of the single-detector gamma camera market going forward. The prevalence of cancer and cardiovascular diseases refers to the number of individuals within a population living with any form of cancer or heart and blood-vessel disorder during a specific time period. The prevalence of these conditions is increasing as populations age and exposure to risk factors such as unhealthy diets and physical inactivity rises, making individuals more susceptible to these diseases. Single-detector gamma cameras support the diagnosis of cancer and cardiovascular diseases by providing essential nuclear imaging that enables clinicians to detect, evaluate, and monitor functional changes in organs affected by cancer and heart conditions. For instance, in August 2025, according to the Centers for Disease Control and Prevention, a Switzerland-based public health agency, nearly 90% of the nation’s $4.9 trillion in annual healthcare spending was attributed to individuals with chronic and mental health conditions, with more than 84,000 Americans dying each year from heart disease or stroke and costs related to cardiovascular diseases projected to reach approximately $2 trillion by 2050. Therefore, the rising prevalence of cancer and cardiovascular diseases is driving the growth of the single-detector gamma camera market.

The growing demand for nuclear medicine imaging is expected to further propel the growth of the single-detector gamma camera market going forward. Nuclear medicine imaging involves the use of small amounts of radioactive materials to visualize and diagnose diseases such as cancer, cardiovascular disorders, and neurological conditions by providing functional and molecular-level information. The increasing demand for nuclear medicine imaging is driven by the rising burden of chronic and complex diseases and the need for accurate and advanced diagnostic solutions. Single-detector gamma cameras support nuclear medicine imaging by delivering reliable, cost-effective, and high-resolution imaging for the detection and monitoring of a wide range of medical conditions. For instance, in September 2025, according to AMN Healthcare, a US-based healthcare workforce solutions provider, employment of nuclear medicine technologists is projected to grow by 8% through 2031, faster than the average for all occupations, with national average salaries ranging from $68,000 to $95,000 annually and experienced professionals earning significantly higher wages. Therefore, the increasing demand for nuclear medicine imaging is contributing to the growth of the single-detector gamma camera market.

In May 2023, TTG Imaging Solutions LLC, a US-based provider of end-to-end diagnostic imaging solutions, acquired Digirad Health Inc. for $40 million. Through this acquisition, TTG sought to expand its national presence in nuclear medicine imaging and broaden its portfolio of fixed and mobile solid-state nuclear medicine cameras, strengthening its service offerings and competitive position across hospitals and outpatient imaging centers. Digirad Health Inc. is a US-based medical imaging technology company specializing in single-detector gamma camera systems and other solid-state nuclear medicine imaging solutions.

Major companies operating in the single-detector gamma camera market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Digirad Corporation, Serac Life Sciences Limited, Biodex Medical Systems Inc., Beijing Huitai Medical Equipment Co. Ltd., Electronic & Engineering Co. Private Limited, DVS Medical Inc., NUVIATech Instruments, Dilon Technologies Inc., Serac Imaging Systems Limited, RadRays Medical Technology, AdvanScint Imaging Solutions, MedNova Imaging Ltd., GBT Medical Technologies, United Imaging Healthcare Co. Ltd.

North America was the largest region in the single-detector gamma camera market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-detector gamma camera market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-detector gamma camera market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have moderately impacted the single-detector gamma camera market by increasing the cost of imported detectors, electronic components, and imaging subsystems, affecting overall system pricing and procurement cycles. hospitals and diagnostic imaging centers in regions such as asia-pacific, latin america, and europe are most affected, particularly for mobile and specialized gamma camera segments. supply chain disruptions have also led to longer installation timelines. however, tariffs have encouraged localized manufacturing, supplier diversification, and regional assembly, strengthening long-term market resilience.

A single-detector gamma camera is a nuclear imaging device that uses a single detector to capture gamma radiation emitted by radiopharmaceuticals inside the body. It is primarily used to generate functional images of organs and tissues for diagnostic purposes, supporting the detection, evaluation, and monitoring of conditions such as cancer, cardiovascular diseases, and bone disorders.

The primary detector types used in single-detector gamma cameras are high-energy general-purpose gamma cameras, low-energy high-resolution gamma cameras, and specialized gamma cameras. High-energy general-purpose gamma cameras are imaging systems designed to detect high-energy gamma emissions for a broad range of nuclear medicine diagnostic procedures. These cameras are available in stationary and mobile designs, based on technologies such as static imaging, dynamic imaging, tomographic imaging including single photon emission computed tomography, and quantitative imaging, used in applications such as oncology, cardiology, neurology, bone scintigraphy, and pulmonary scintigraphy, among end users including hospitals, diagnostic imaging centers, research institutions, and outpatient clinics.

The single-detector gamma camera market consists of sales of single-detector gamma camera systems, gamma camera imaging heads, data acquisition and processing units, collimators, radiation detection crystals, and associated imaging software used for nuclear medicine diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.